These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20830829)

  • 1. Duration of clopidogrel therapy with drug-eluting stents.
    Rennings AJ; Schouwenberg BJ; van Onzenoort HA
    N Engl J Med; 2010 Jul; 363(5):489; author reply 490. PubMed ID: 20830829
    [No Abstract]   [Full Text] [Related]  

  • 2. Duration of clopidogrel therapy with drug-eluting stents.
    Knosalla C; Dandel M; Hetzer R
    N Engl J Med; 2010 Jul; 363(5):489-90; author reply 490. PubMed ID: 20830830
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacodynamic effect of clopidogrel therapy and switching to cilostazol in patients with the CYP2C19 loss-of-function allele (ACCEL-SWITCH) study.
    Jeong YH; Park Y; Muse WC; Kwon TJ; Koh JS; Hwang SJ; Kwak CH; Hwang JY
    J Thromb Haemost; 2012 Aug; 10(8):1685-8. PubMed ID: 22612904
    [No Abstract]   [Full Text] [Related]  

  • 4. Duration of clopidogrel therapy with drug-eluting stents.
    Okura H
    N Engl J Med; 2010 Jul; 363(5):488; author reply 490. PubMed ID: 20666628
    [No Abstract]   [Full Text] [Related]  

  • 5. Duration of clopidogrel therapy with drug-eluting stents.
    Memtsoudis SG; Sharrock NE
    N Engl J Med; 2010 Jul; 363(5):488-9; author reply 490. PubMed ID: 20830828
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement.
    Hochholzer W; Trenk D; Fromm MF; Valina CM; Stratz C; Bestehorn HP; Büttner HJ; Neumann FJ
    J Am Coll Cardiol; 2010 Jun; 55(22):2427-34. PubMed ID: 20510210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of concomitant use of rabeprazole during dual-antiplatelet therapy with clopidogrel and aspirin after drug-eluting stent implantation: a retrospective cohort study].
    Yasu T; Ikee R; Miyasaka Y; Chubachi H; Saito S
    Yakugaku Zasshi; 2010 Dec; 130(12):1743-50. PubMed ID: 21139402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for the ceiling: new reflections on the disposition and metabolism of clopidogrel.
    Kleiman NS
    JACC Cardiovasc Interv; 2008 Dec; 1(6):628-30. PubMed ID: 19463376
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trial.
    Gladding P; Webster M; Zeng I; Farrell H; Stewart J; Ruygrok P; Ormiston J; El-Jack S; Armstrong G; Kay P; Scott D; Gunes A; Dahl ML
    JACC Cardiovasc Interv; 2008 Dec; 1(6):620-7. PubMed ID: 19463375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet reactivity in the early and late phases of acute coronary syndromes according to cytochrome P450 2C19 phenotypes.
    Nagashima Z; Tsukahara K; Morita S; Endo T; Sugano T; Hibi K; Himeno H; Fukui K; Umemura S; Kimura K
    J Cardiol; 2013 Sep; 62(3):158-64. PubMed ID: 23886632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard- vs high-dose clopidogrel after percutaneous coronary intervention.
    Jeong YH; Park Y; Kim IS
    JAMA; 2011 Jun; 305(24):2520; author reply 2521-2. PubMed ID: 21693737
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus after drug-eluting stent implantation in Japanese patients receiving clopidogrel.
    Sawada T; Shinke T; Shite J; Honjo T; Haraguchi Y; Nishio R; Shinohara M; Toh R; Ishida T; Kawamori H; Kozuki A; Inoue T; Hariki H; Hirata K
    Circ J; 2011; 75(1):99-105. PubMed ID: 21099121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 2C19 polymorphism and clopidogrel after MI.
    Ramaraj R
    Lancet; 2009 Apr; 373(9670):1172; author reply 1172-3. PubMed ID: 19345827
    [No Abstract]   [Full Text] [Related]  

  • 14. The worry about clopidogrel "nonresponsiveness": identification and treatment in the post-percutaneous coronary intervention patient.
    Gurbel PA; Tantry US; Shuldiner AR
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1102-4. PubMed ID: 19926051
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects.
    Hulot JS; Wuerzner G; Bachelot-Loza C; Azizi M; Blanchard A; Peyrard S; Funck-Brentano C; Gaussem P
    J Thromb Haemost; 2010 Mar; 8(3):610-3. PubMed ID: 20040040
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of CYP2C19 genotype with periprocedural myocardial infarction after uneventful stent implantation in Chinese patients receiving clopidogrel pretreatment.
    Wu H; Qian J; Sun A; Wang Q; Ge J
    Circ J; 2012; 76(12):2773-8. PubMed ID: 22971905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beware of being caught on the rebound.
    Lordkipanidzé M; Harrison P
    J Thromb Haemost; 2011 Jan; 9(1):21-3. PubMed ID: 21210949
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy.
    Scott SA; Sangkuhl K; Gardner EE; Stein CM; Hulot JS; Johnson JA; Roden DM; Klein TE; Shuldiner AR;
    Clin Pharmacol Ther; 2011 Aug; 90(2):328-32. PubMed ID: 21716271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.
    Trenk D; Hochholzer W; Fromm MF; Chialda LE; Pahl A; Valina CM; Stratz C; Schmiebusch P; Bestehorn HP; Büttner HJ; Neumann FJ
    J Am Coll Cardiol; 2008 May; 51(20):1925-34. PubMed ID: 18482659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CYP2C19 gene polymorphism in patients with myocardial infarction who use clopidogrel].
    Galiavich AS; Valeeva DD; Minnetdinov RSh; Arkhipova AA; Akhmetov II; Galiavi RA
    Kardiologiia; 2012; 52(4):20-4. PubMed ID: 22839512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.